Jae-Ouk Kim

Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine

M. Song, J. Lovell, Chankyu Lee, 2022, BMC Medicine.